Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease
James Lee(Royal Free London NHS Foundation Trust), Kenneth G. C. Smith(The University of Melbourne), Carl A. Anderson(Wellcome Sanger Institute), Richard B. Gearry(Waitaki Biosciences (New Zealand)), John Mansfield(Newcastle University), James A. Traherne(University of Cambridge), Paul Lyons(Cambridge School), Luke Jostins(Wellcome Sanger Institute), Jack Satsangi(Western General Hospital), Miles Parkes(Cambridge University Hospitals NHS Foundation Trust), Tariq Ahmad(National Health Service), David C. Wilson(University of Edinburgh), Daniele Biasci(University of Cambridge), Rebecca Roberts(University of Otago), Natalie J. Prescott(Guy's Hospital)
Cited by 311
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k